The Insides Company

The Insides Company is a New Zealand-based medtech firm founded in 2017, specializing in automated chyme reinfusion solutions for patients with severe intestinal failure.

The company aims to provide universal access to chyme reinfusion therapy, establishing a new standard of care for those recovering from intestinal issues. It operates from its headquarters in Auckland and has a team of 17 employees. The Insides® System is the company's flagship product, designed to safely reinfuse digestive fluid back into the lower intestine. This device allows patients to resume oral feeding, reduce reliance on parenteral nutrition, and restore digestion and nutrient absorption. It is prescribed for various conditions, including high-output enteroatmospheric fistulas and intestinal discontinuity due to trauma or disease. The company is ISO 13485 certified and has received accolades, including a gold award at the International Medical Design Excellence Awards in 2021. The Insides System is available in 10 countries, with plans for expansion, and is recognized for its potential to significantly reduce treatment costs.